The resultswere supported by mRNA expression experiments of αSMA, Col1α1, P53, and Ki67. As proof of principle, the effects of FDA-approvedantifibrotic drugs nintedanib and pirfenidone were tested in our newlydeveloped fibrosis model. Here, ACTA1 is linked to fibrosis.